Literature DB >> 35619555

Self-amplifying loop of NF-κB and periostin initiated by PIEZO1 accelerates mechano-induced senescence of nucleus pulposus cells and intervertebral disc degeneration.

Jinna Wu1, Yuyu Chen1, Zhiheng Liao1, Hengyu Liu1, Shun Zhang1, Dongmei Zhong2, Xianjian Qiu3, Taiqiu Chen3, Deying Su4, Xiaona Ke1, Yong Wan1, Taifeng Zhou5, Peiqiang Su6.   

Abstract

Abnormal mechanical load is a main risk factor of intervertebral disc degeneration (IDD), and cellular senescence is a pathological change in IDD. In addition, extracellular matrix (ECM) stiffness promotes human nucleus pulposus cells (hNPCs) senescence. However, the molecular mechanism underlying mechano-induced cellular senescence and IDD progression is not yet fully elucidated. First, we demonstrated that mechano-stress promoted hNPCs senescence via NF-κB signaling. Subsequently, we identified periostin as the main mechano-responsive molecule in hNPCs through unbiased sequencing, which was transcriptionally upregulated by NF-κB p65; moreover, secreted periostin by senescent hNPCs further promoted senescence and upregulated the catabolic process in hNPCs through activating NF-κB, forming a positive loop. Both Postn (encoding periostin) knockdown via siRNA and periostin inactivation via neutralizing antibodies alleviated IDD and NPCs senescence. Furthermore, we found that mechano-stress initiated the positive feedback of NF-κB and periostin via PIEZO1. PIEZO1 activation by Yoda1 induced severe IDD in rat tails without compression, and Postn knockdown alleviated the Yoda1-induced IDD in vivo. Here, we reported for the first time that self-amplifying loop of NF-κB and periostin initiated via PIEZO1 under mechano-stress accelerated NPCs senescence, leading to IDD. Furthermore, periostin neutralizing antibodies, which may serve as potential therapeutic agents for IDD, interrupted this loop.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cellular senescence; Intervertebral disc degeneration; NF-κB; PIEZO1; Periostin; Senescence-associated secretory phenotype

Mesh:

Substances:

Year:  2022        PMID: 35619555      PMCID: PMC9552911          DOI: 10.1016/j.ymthe.2022.05.021

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   12.910


  54 in total

Review 1.  Equilibrium of the human body and the gravity line: the basics.

Authors:  J C Le Huec; R Saddiki; J Franke; J Rigal; S Aunoble
Journal:  Eur Spine J       Date:  2011-08-02       Impact factor: 3.134

Review 2.  Periostin as a multifunctional modulator of the wound healing response.

Authors:  John T Walker; Karrington McLeod; Shawna Kim; Simon J Conway; Douglas W Hamilton
Journal:  Cell Tissue Res       Date:  2016-05-28       Impact factor: 5.249

3.  Alterations in the mechanical behavior of the human lumbar nucleus pulposus with degeneration and aging.

Authors:  J C Iatridis; L A Setton; M Weidenbaum; V C Mow
Journal:  J Orthop Res       Date:  1997-03       Impact factor: 3.494

4.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

Authors:  K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo
Journal:  J Bone Miner Res       Date:  1999-07       Impact factor: 6.741

5.  Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13.

Authors:  Mukundan Attur; Qing Yang; Kohei Shimada; Yuki Tachida; Hiroyuki Nagase; Paolo Mignatti; Lauren Statman; Glyn Palmer; Thorsten Kirsch; Frank Beier; Steven B Abramson
Journal:  FASEB J       Date:  2015-06-19       Impact factor: 5.191

Review 6.  Low back pain.

Authors:  Nebojsa Nick Knezevic; Kenneth D Candido; Johan W S Vlaeyen; Jan Van Zundert; Steven P Cohen
Journal:  Lancet       Date:  2021-06-08       Impact factor: 79.321

Review 7.  Cell-based strategies for IVD repair: clinical progress and translational obstacles.

Authors:  Abbie L A Binch; Joan C Fitzgerald; Emily A Growney; Frank Barry
Journal:  Nat Rev Rheumatol       Date:  2021-02-01       Impact factor: 32.286

Review 8.  Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions.

Authors:  Feng-Juan Lyu; Haowen Cui; Hehai Pan; Kenneth Mc Cheung; Xu Cao; James C Iatridis; Zhaomin Zheng
Journal:  Bone Res       Date:  2021-01-29       Impact factor: 13.567

9.  Inflammatory signaling sensitizes Piezo1 mechanotransduction in articular chondrocytes as a pathogenic feed-forward mechanism in osteoarthritis.

Authors:  Whasil Lee; Robert J Nims; Alireza Savadipour; Qiaojuan Zhang; Holly A Leddy; Fang Liu; Amy L McNulty; Yong Chen; Farshid Guilak; Wolfgang B Liedtke
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

10.  Periostin loss-of-function protects mice from post-traumatic and age-related osteoarthritis.

Authors:  Mukundan Attur; Xin Duan; Lei Cai; Tianzhen Han; Weili Zhang; Eric D Tycksen; Jonathan Samuels; Robert H Brophy; Steven B Abramson; Muhammad Farooq Rai
Journal:  Arthritis Res Ther       Date:  2021-04-08       Impact factor: 5.156

View more
  1 in total

1.  Dihydroartemisinin Attenuated Intervertebral Disc Degeneration via Inhibiting PI3K/AKT and NF-κB Signaling Pathways.

Authors:  Zhiheng Liao; Deying Su; Hengyu Liu; Caixia Xu; Jinna Wu; Yuyu Chen; Weimin Guo; Shun Zhang; Zhuling Li; Xiaona Ke; Tingting Wang; Taifeng Zhou; Peiqiang Su
Journal:  Oxid Med Cell Longev       Date:  2022-09-09       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.